Malignant hyperthermia and day stay surgery

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Malignant hyperthermia (MH) susceptibility often necessitates overnight observation for patients, even after minor procedures.
• MH-susceptible patients may be excluded from day stay surgical units.
• Current practices may lead to prolonged hospital stays and increased healthcare costs for MH-susceptible individuals.

Purpose of the Study:

• To investigate the safety and feasibility of managing malignant hyperthermia susceptible patients as day stay surgical patients.
• To determine if MH-susceptible patients can receive anesthesia and undergo procedures without adverse hyperthermia reactions in an outpatient setting.

Main Methods:

• A four-year prospective audit (from late 2000) included MH-susceptible patients and untested relatives undergoing day stay anesthesia.
• Data collected included MH status, age, anesthesia duration, technique (trigger-free), procedure type, and intraoperative/postoperative monitoring.
• Patients received detailed postoperative care unit monitoring and were observed for 2.5 hours postoperatively.

Main Results:

• Seventy-two patients were included; 85% received general anesthesia, 15% regional anesthesia.
• Only minor postoperative complications occurred, with no signs suggestive of a malignant hyperthermia reaction.
• Follow-up calls to 68% of patients the next day revealed no evidence of MH reactions.

Conclusions:

• Malignant hyperthermia susceptible patients can be safely managed in day stay surgical settings.
• Appropriate facilities and postoperative care protocols are crucial for the safe outpatient management of MH-susceptible patients.
• This approach can potentially reduce hospital admissions and improve patient flow for elective procedures.